Alchemy Labs Inc.

As of June 30, 2026, ALCHEMY LABS INC has 54.56M shares outstanding.

As of June 30, 2026, ALCHEMY LABS INC maintains a current ratio of 0.26, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -141.71, indicating conservative leverage, while an interest coverage ratio of -2.30 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, ALCHEMY LABS INC recorded an income tax benefit of -1,917.26 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -4.90M and -4.90M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, ALCHEMY LABS INC generated 1.04M in revenue and converted that into -4.90M in net income, yielding earnings per share of -0.09. EBITDA reached -3.02M, while operating income came in at -3.22M.

As of June 30, 2026, ALCHEMY LABS INC holds 887,688.93 in cash and equivalents against 6.18M in total debt, resulting in a net debt position of 5.17M. Total book value stands at -4.36M, with working capital of -6.08M providing operational flexibility.

ALCHEMY LABS INC produced -3.01M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.16M in capital expenditures, free cash flow totaled -4.17M - equivalent to -0.08 per share.

Over the twelve months ended June 30, 2026, ALCHEMY LABS INC posted a gross margin of 12.02, reflecting its pricing power and cost economics. The operating margin of -310.35 and net profit margin of -471.69 provide insight into operational efficiency.